BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18474510)

  • 21. Listeria monocytogenes joint infection in a patient with psoriatic arthritis.
    Marangos MN; Keroack BJ; Claffey TF
    J Rheumatol; 1996 Nov; 23(11):2005-6. PubMed ID: 8923390
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report.
    Balbir-Gurman A; Guralnik L; Best LA; Vlodavsky E; Yigla M; Menahem Nahir A; Braun-Moscovici Y
    J Clin Rheumatol; 2009 Feb; 15(1):29-30. PubMed ID: 18679135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug use and toxicity in psoriatic disease: focus on methotrexate.
    Taylor WJ; Korendowych E; Nash P; Helliwell PS; Choy E; Krueger GG; Soriano ER; McHugh NJ; Rosen CF
    J Rheumatol; 2008 Jul; 35(7):1454-7. PubMed ID: 18609744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical image. Extensive oral ulcerations.
    Goksugur N; Yilmaz F
    N Z Med J; 2006 Sep; 119(1242):U2236. PubMed ID: 16998578
    [No Abstract]   [Full Text] [Related]  

  • 27. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 28. Methotrexate therapy for psoriatic arthritis: reappraisal of an old remedy.
    Saketkoo LA; Cuchacovich R; Espinoza LR
    J Rheumatol; 2008 Mar; 35(3):369-71. PubMed ID: 18322970
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate in psoriatic arthritis.
    Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Encephalopathy secondary to methotrexate].
    Martínez-Raposo Piedrafita MC; Esteban Jiménez O; Baile Estopañán G; Navarro Pemán C
    Med Clin (Barc); 2010 May; 134(14):662-3. PubMed ID: 19464710
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Methotrexate: safe if prescribed correctly].
    Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
    Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous bleeding in a patient of rheumatoid arthritis: a complication after accidental overdose of methotrexate.
    Chakraborty PP; Achar A
    J Assoc Physicians India; 2007 Jul; 55():501. PubMed ID: 17907499
    [No Abstract]   [Full Text] [Related]  

  • 36. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate.
    Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S
    Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress fracture in long term methotrexate treatment for psoriatic arthritis.
    Wijnands M; Burgers A
    Ann Rheum Dis; 2001 Aug; 60(8):736-9. PubMed ID: 11454635
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversible posterior leucoencephalopathy during oral treatment with methotrexate.
    Renard D; Westhovens R; Vandenbussche E; Vandenberghe R
    J Neurol; 2004 Feb; 251(2):226-8. PubMed ID: 14991361
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hairy cell leukemia during treatment of psoriatic polyarthritis with methotrexate].
    Chaudier B; Chouc PY; Fulpin J; Bouvenot G; Sebahoun G; Jeandel P
    Presse Med; 1999 Sep; 28(27):1467-8. PubMed ID: 10520317
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):8-12. PubMed ID: 20510169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.